Press Releases

Sami-Sabinsa ends the year with more good news about achievements. The Confederation of Indian Industry (CII) recognized the Sami-Sabinsa Group with two awards for IP property, and Sami-Sabinsa Founder and Chairman, Dr. Muhammed Majeed, was honored by the Indian Association for the Study of Traditional Asian Medicine (IASTAM)…

Sabinsa’s proprietary formulation Macumax^® was shown to have vision health benefits in a clinical trial on subjects diagnosed with age-related macular degeneration (AMD)…

Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group was honored with a lifetime achievement award in recognition of his exemplary services in the nutraceuticals and cosmeceuticals industry by ASSOCHAM (The Associated Chambers of Commerce and Industry of India)…

Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group has recently published the fourth book in a series on derivatives of Boswellia serrata…

Sabinsa, a pioneer in the nutraceutical and cosmeceutical industry, has provided documentation to appropriate government agencies in its continuing efforts to identify and remove adulterated vitamin C additives from the market, a practice to which Sabinsa alerted the industry earlier this year…

Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, is offering glyphosate test results to customers, using a proprietary method for testing glyphosate developed by scientists at parent company Sami-Sabinsa…

Sabinsa, a pioneer in the nutraceutical and cosmeceutical industries, has expanded its large portfolio of intellectual property…

Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, has strengthened its market position in Canada with the grant of three new patents. The company has also received an additional Natural Products Number (NPN) issued by Health Canada, bringing their total number of products with health claims in Canada to 37…

Disruptions from the COVID-19 pandemic have caused hardship across the world, with the poorest people in India hit particularly hard. With the objective of helping to alleviate food insecurity, the Dr. Majeed Foundation gave 5,500 rice bags of 10 kilo each to the people of Magadi, Karnataka on September 24, 2020…

Sabinsa, the leading nutraceutical ingredients company with patents throughout the world, has expanded its portfolio of intellectual property with a new patent granted in Mexico for Saberry^®…

A clinical study on Sabinsa’s patented hair serum formulation was found to significantly improve hair fall and thinning. “Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall” by Majeed M, Majeed S, Nagabhushanam K, Mundkur L, Neupane P and Shah K was published in Clinical, Cosmetic and Investigational Dermatology (2020:13 691–700)…

As Sabinsa’s R&D Scientists expanded their understanding of probiotics, and developed new products based upon that increased knowledge, it was inevitable that published studies would soon follow…

Sabinsa has sent a cease & desist letter to Applied Food Sciences (AFS) for making claims of high levels of natural vitamin C in that company’s branded amla (Emblica officinalis) extract….

Sabinsa, the pioneer of ingredients conceived by modern science drawing from traditional Ayurvedic knowledge, announces a new combination to support healthy liver function, LivLonga^®, giving a boost to a category teeming with dated, generic products…

Sabinsa is pleased to announce that several of the company’s ingredients have been Non-GMO Project Verified, adding to the value the end-user finds in Sabinsa’s transparency and commitment to natural, sustainable, and Non-GMO ingredients…

Sabinsa’s Curcumin C3 Complex^®, the #1 clinically studied curcumin brand on the market, is the subject of a recently published study on its effect, combined with BioPerine^®, on serum cytokine concentrations…

The Dr. Majeed Foundation, a non-profit institution established by Dr. Muhammed Majeed, Founder and Chairman of Sami-Sabinsa Group, has channeled significant support to people impacted by the COVID-19 pandemic…

Material Claiming Naturally High Amounts of Vitamin C IRMS-Tested, Establishing It as Non-Amla, Fermentation Source…

In these uncertain days of the highly contagious coronavirus, the absence of pharmaceutical intervention in the form of drugs or vaccines has pushed scientists to look for clues among safe herbal extract ingredients. A recent peer-reviewed scientific article co-authored by the founder and chairman of Sabinsa, Dr. Muhammed Majeed…

Two new studies have recently been published on the topical benefits of Sabinsa’s pTeroWhite^® natural pterostilbene isolated and purified from Pterocarpus marsupium heartwood and formulated as a cream. The studies further the body of science into pTeroWhite’s value as a cosmeceutical ingredient for anti-aging, skin brightening, and as a natural SPF agent…

Sami-Sabinsa Group, a pioneer and global leader in health science, was honored with three awards by the Associated Chambers of Commerce and Industry of India (ASSOCHAM) at the 3rd edition of their Beauty, Wellness and Personal Care Awards held in New Delhi on February 28, 2020…

Shaheen Majeed, President Worldwide, to speak about sustainability…

Sami-Sabinsa Group hosted a ground-breaking ceremony, on January 20, 2020, for a new Active Pharmaceutical Ingredients (API) manufacturing unit at Pharma SEZ Industrial Area, Hassan, Karnataka…

When the fastest growing 50 companies in New Jersey were announced by NJBIZ, a leading business journal in the state, Sabinsa was pleased to be identified as the 15th of the Fast 50…

Sabinsa has been granted U.S. patent US10166261 for a method of managing dementia and dementia-related sleep disorders presented as symptoms of major depressive disorder (MDD) in humans associated with Irritable Bowel Syndrome (IBS) by administering Bacillus coagulans MTCC 5856 (LactoSpore^®) at a dose of 2 billion colony forming units per day…

A new study collaboratively published by Sabinsa researchers and academic scientists from Taiwan and China, demonstrates that Sabinsa’s sustainably-sourced pterostilbene attenuates Trimethylamine-N-oxide (TMAO) formation…

Sabinsa’s parent company Sami Labs Limited received The Economic Times’ Business Leaders 2019 Award for Most Trusted Nutraceutical Company in a ceremony held in Mumbai, India last month. The Economic Times, is the leading financial daily in India and among the world’s top three daily newspapers…

The Sami-Sabinsa Group’s export success was recently recognized by the Visveshwaraiah Trade Promotion Centre (VTPC), under the auspices of the Industries Department, Government of Karnataka, India. Sabinsa’s parent company Sami Labs Limited received three Export Excellence Awards…

Sabinsa’s Curcumin C3 Complex^®, the #1 researched curcumin ingredient on the market, was used in a new published study on Non-Alcoholic Fatty Liver Disease (NAFLD), the most common chronic liver condition for which no approved pharmaceutical treatments exist…

The Sami-Sabinsa Group was honored with numerous awards in recent weeks, being named “best of” in categories ranging from herbal research to beverage taste. The Sami-Sabinsa Group’s founder, Chairman, and Managing Director, Dr. Muhammed Majeed, was commended as well…

Sabinsa’s founder, Chairman, and Managing Director Dr. Muhammed Majeed announced the publication of a new book; this latest is entitled “Reductive Metabolites of Curcuminoids.” Over the last two decades curcuminoids have been the most intensively studied herbal constituents, and Sabinsa has been at the forefront of much of the research…

Sabinsa is the official Curcumin Sponsor of SupplySide West, to be held October 17 – 18, 2019, at the Mandalay Bay Convention Center, Las Vegas, NV. The company will highlight several condition-specific branded ingredient products from its extensive portfolio in booth #4131…

The body of research supporting efficacy of Sabinsa’s branded ingredients continues to grow with a recent clinical paper reporting on the use of the company’s Curcumin C3 Complex^® and BioPerine^®,…

Sabinsa’s Curcumin C3 Complex^® in combination with BioPerine^® (CBP) has an inhibitory effect on malignant mesothelioma cells, according to an in vitro and in vivo study published in Journal of Experimental and Clinical Cancer Research…

Sabinsa continues its global expansion with the opening of a warehousing, sales and distribution office in Poland and bringing on staff to serve customers in the growing East European, Eastern Block as well as CIS countries….

Sabinsa’s four Sami Labs manufacturing sites in India were recently audited by the licensed Certification Body, Bureau Veritas Certification Holding SAS – UK branch, and achieved Foundation Food Safety System Certification 22000 (FSSC 22000)…

Sabinsa’s Curcumin C3 Complex^® has been studied as an adjuvant therapy with several cancer drugs in the past, and the body of science continues to grow with the recent publication of more positive research…

After a comprehensive review of safety and toxicology data by an independent panel of scientists of international repute convened by Soni & Associates Inc., Sabinsa’s patented color-free Curcumin C3 Reduct^® tetrahydrocurcuminoids, a metabolite of curcumin, has been found to meet criteria as Generally Recognized As Safe (GRAS) as per FDA’s scientific procedures…

Three additional Sami-Sabinsa Group Manufacturing units have been audited by the United States Pharmacopeia (USP) and received GMP compliance certificates for the Kunigal unit and the Dobaspet unit, both in Bengaluru, India, and the Hyderabad unit in Telangana state, India…

A retrospective analysis of curcumin research presented a comprehensive look at the vast body of science on the popular extract of turmeric. Curcumin: Total-Scale Analysis of the Scientific Literature…

Sabinsa will feature two new patent-protected branded ingredients at New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day tradeshow May 7 – 8, 2019…

The Department of Scientific and Industrial Research (DSIR), under the Government of India’s Ministry of Science and Technology has sanctioned funding to Sabinsa’s parent company Sami Labs…

The Sami-Sabinsa Group’s Nelamangala biotechnology site in Bengaluru, India has been audited by the United States Pharmacopeia (USP) and received a GMP compliance certificate…

Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423…

Sabinsa announces the introduction of LactoSporin^®, an ingredient for cosmeceutical products that has antimicrobial, antioxidant, anti-inflammatory, and anti-collagenase properties…

The Sami-Sabinsa Group’s Executive Vice President of R&D and Senior Advisor Dr. Sankaran Natarajan was honored by the Indian Association for the Study of Traditional Asian Medicine (IASTAM)…

Sabinsa is pleased to announce that Lori Diez has joined the company as Sales Manager – Texas…

Sabinsa has raised the quality bar for the popular adaptogen ashwagandha with Shagandha^™Ashwagandha Root Extract 2.5% USP from Withania somnifera, assured to comply with the U.S. Pharmacopoeia-National Formulary (USP-NF) monograph…

A recent peer-reviewed study reported the results of an investigation into the functional aspects of Sabinsa’s shelf stable probiotic Bacillus coagulans MTCC 5856, known worldwide as LactoSpore^®…